Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Withdrawal of E.U. marketing authorization for Fortovase

Aug. 14, 2006

New chemokine receptor ligands for HIV reported in recent GSK patent

Aug. 10, 2006

Phase II study of IR-103 in HIV patients cleared to add French sites

Aug. 7, 2006

Novel therapeutic agents for HIV infection reported by Tibotec, Pfizer

Aug. 2, 2006

Phase I study findings for IV DNA + protein vaccine DP6-001

Aug. 2, 2006

Study of VGV-1 shows HIV viral load reductions

July 27, 2006

Recent ViroChem patent reports novel HIV integrase inhibitors

July 20, 2006

BioInvent to focus on back-up compounds to BI-201 in HIV

July 17, 2006

FDA approves Atripla, first once-daily single tablet regimen for HIV

July 13, 2006

New therapeutic agents for HIV infection disclosed in recent patents

July 11, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...